Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00828412 · ClinicalTrials.gov registry record · Phase 4
Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis
A Phase 4 study, sponsored by Promius Pharma.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
NCT00828412: Completed Phase 4 study, sponsored by Promius Pharma.
NCT00828412 is a Phase 4 study that has completed, run by Promius Pharma. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00828412, a Phase 4 study, has completed, sponsored by Promius Pharma.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.
Primary Outcome
The average of the sum of scores for erythema, edema/papulation, and excoriation for two target lesions. Scoring on a scale of 0 to 3 (none to severe). Maximum score is 9.
Interventions
- DEVICE EpiCeram Skin Barrier Emulsion
- DRUG Desonide Cream 0.05%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2009-03 |
| Est. Completion | 2009-08 |
| Phase | Phase 4 |
What the finished NCT00828412 record still lists
NCT00828412 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which EpiCeram Skin Barrier Emulsion is the first listed.
NCT00828412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00828412 about?
NCT00828412 is a clinical study titled "Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis". This study compares the effectiveness of two topical creams for atopic dermatitis in pediatric subjects. Subjects will be randomly assigned to use one of the two creams twice daily for 6 weeks or until clear.
What is the current status of trial NCT00828412?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2009-03. Estimated completion is 2009-08.
What interventions are being tested in trial NCT00828412?
The interventions under investigation include: EpiCeram Skin Barrier Emulsion (DEVICE), Desonide Cream 0.05% (DRUG).
Who is sponsoring clinical trial NCT00828412?
This trial is sponsored by Promius Pharma, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00828412's enrollment target sits among peer trials
100 770th of 2000 higher than 1,148 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia